These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38396300)

  • 1. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.
    Benedetti DJ; Renfro LA; Tfirn I; Daw NC; Kalapurakal JA; Ehrlich PF; Khanna G; Perlman E; Warwick A; Gow KW; Paulino AC; Seibel NL; Grundy P; Fernandez CV; Geller JI; Mullen EA; Dome JS
    Cancer; 2024 Jul; 130(13):2361-2371. PubMed ID: 38396300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).
    Seibel NL; Chi YY; Perlman EJ; Tian J; Sun J; Anderson JR; Ritchey ML; Thomas PR; Miser J; Kalapurakal JA; Grundy PE; Green DM
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27450. PubMed ID: 30255545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of children with clear cell sarcoma of kidney following NWTS strategies in Shanghai China (2003-2021).
    Zhang A; Yuan X; Jiang S; Xu D; Huang C; Tang JY; Gao Y
    PLoS One; 2024; 19(7):e0306863. PubMed ID: 38980838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.
    Daw NC; Chi YY; Kalapurakal JA; Kim Y; Hoffer FA; Geller JI; Perlman EJ; Ehrlich PF; Mullen EA; Warwick AB; Grundy PE; Paulino AC; Gratias E; Ward D; Anderson JR; Khanna G; Tornwall B; Fernandez CV; Dome JS;
    J Clin Oncol; 2020 May; 38(14):1558-1568. PubMed ID: 32134700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
    Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
    J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
    Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE;
    Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
    Dix DB; Seibel NL; Chi YY; Khanna G; Gratias E; Anderson JR; Mullen EA; Geller JI; Kalapurakal JA; Paulino AC; Perlman EJ; Ehrlich PF; Malogolowkin M; Gastier-Foster JM; Wagner E; Grundy PE; Fernandez CV; Dome JS
    J Clin Oncol; 2018 Jun; 36(16):1564-1570. PubMed ID: 29659330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Moksness J; Finklestein JZ; D'Angio GJ
    J Clin Oncol; 1994 Oct; 12(10):2132-7. PubMed ID: 7931484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
    J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries.
    Zekri W; Alfaar AS; Yehia D; Elshafie MM; Zaghloul MS; El-Kinaai N; Taha H; Refaat A; Younes AA
    Pediatr Blood Cancer; 2014 Dec; 61(12):2185-90. PubMed ID: 25175045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of outcomes in patients with clear cell sarcoma of the kidney: A tertiary single-institution experience.
    Dong JJ; He XY; Liu X; Lin T; He DW; Liu F; Wei GH
    J Pediatr Surg; 2021 Mar; 56(3):580-586. PubMed ID: 33272561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
    Lovvorn HN; Renfro LA; Benedetti DJ; Kotagal M; Phelps HM; Ehrlich PF; Lo AC; Sandberg JK; Treece AL; Gow KW; Glick RD; Davidoff AM; Cost NG; Dix DB; Fernandez CV; Dome JS; Geller JI; Mullen EA
    J Am Coll Surg; 2024 Apr; 238(4):733-749. PubMed ID: 38251681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis.
    Radulescu VC; Gerrard M; Moertel C; Grundy PE; Mathias L; Feusner J; Diller L; Dome JS
    Pediatr Blood Cancer; 2008 Feb; 50(2):246-9. PubMed ID: 17226850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
    Dix DB; Fernandez CV; Chi YY; Mullen EA; Geller JI; Gratias EJ; Khanna G; Kalapurakal JA; Perlman EJ; Seibel NL; Ehrlich PF; Malogolowkin M; Anderson J; Gastier-Foster J; Shamberger RC; Kim Y; Grundy PE; Dome JS;
    J Clin Oncol; 2019 Oct; 37(30):2769-2777. PubMed ID: 31449468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.